Literature DB >> 9725232

Natural killer cell lysis of cytomegalovirus (CMV)-infected cells correlates with virally induced changes in cell surface lymphocyte function-associated antigen-3 (LFA-3) expression and not with the CMV-induced down-regulation of cell surface class I HLA.

J M Fletcher1, H G Prentice, J E Grundy.   

Abstract

CMV and other viruses down-regulate the cell surface expression of class I HLA, and while this allows them to evade CTL, it may make infected cells more susceptible to lysis by NK cells, due to the failure to engage class I inhibitory receptors on the NK cell. We studied CMV infection and found that fibroblasts infected with virus strains Towne, Toledo, Davis, and C1FE were refractory to NK lysis, while those infected with strains AD169, C1F, or R7 were susceptible. All viral strains down-regulated class I HLA to a similar extent, and we concluded that there was no evidence for any correlation between the latter and susceptibility to NK lysis. In contrast, there was a strong correlation between NK killing of CMV-infected cells and cell surface levels of lymphocyte function-associated antigen-3 (LFA-3). Fibroblasts infected with the Towne, Toledo, Davis, and C1FE strains of CMV down-regulated LFA-3 expression and were refractory to lysis, while strains AD169, C1F, and R7 up-regulated LFA-3 and were susceptible to NK killing. U373 MG (malignant glioma) cells expressed constitutively high levels of LFA-3 and were sensitive to NK lysis when infected with any of the above-listed CMV strains. We estimated that a minimum of between 29,000 and 71,000 LFA-3 molecules per target cell were needed for NK susceptibility. The effects on LFA-3 expression were due to immediate early/early viral gene products. We also demonstrated that fibroblasts infected with the strains Towne, Toledo, Davis, and C1FE expressed a ganciclovir-sensitive late CMV gene product, which delivered an inhibitory signal to NK cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9725232

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Protective effect of cytomegalovirus reactivation on relapse after allogeneic hematopoietic cell transplantation in acute myeloid leukemia patients is influenced by conditioning regimen.

Authors:  Shivaprasad Manjappa; Pavan Kumar Bhamidipati; Keith E Stokerl-Goldstein; John F DiPersio; Geoffrey L Uy; Peter Westervelt; Jingxia Liu; Mark A Schroeder; Ravi Vij; Camille N Abboud; Todd A Fehniger; Amanda F Cashen; Iskra Pusic; Meagan Jacoby; Srinidhi J Meera; Rizwan Romee
Journal:  Biol Blood Marrow Transplant       Date:  2013-10-10       Impact factor: 5.742

2.  Graft versus leukemia response without graft-versus-host disease elicited by adoptively transferred multivirus-specific T-cells.

Authors:  Jan J Melenhorst; Paul Castillo; Patrick J Hanley; Michael D Keller; Robert A Krance; Judith Margolin; Ann M Leen; Helen E Heslop; A John Barrett; Cliona M Rooney; Catherine M Bollard
Journal:  Mol Ther       Date:  2014-09-30       Impact factor: 11.454

3.  Cure My Virus: Hematemesis and Melena in a Transplant Recipient.

Authors:  S Sahni; H Kassam; N Yaghooti; A Birg; D M McCarthy
Journal:  Dig Dis Sci       Date:  2021-02-02       Impact factor: 3.199

4.  Investigation on correlation between expression of CD58 molecule and severity of hepatitis B.

Authors:  Li Sheng; Jie Li; Bao-Tai Qi; Yu-Qiang Ji; Zhao-Jun Meng; Ming Xie
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

5.  UL40-mediated NK evasion during productive infection with human cytomegalovirus.

Authors:  Eddie C Y Wang; Brian McSharry; Christelle Retiere; Peter Tomasec; Sheila Williams; Leszek K Borysiewicz; Veronique M Braud; Gavin W G Wilkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

6.  Reduced leukemia relapse through cytomegalovirus reactivation in killer cell immunoglobulin-like receptor-ligand-mismatched cord blood transplantation.

Authors:  Hisayuki Yokoyama; Junya Kanda; Yuta Kawahara; Naoyuki Uchida; Masatsugu Tanaka; Satoshi Takahashi; Makoto Onizuka; Yuma Noguchi; Yukiyasu Ozawa; Yuna Katsuoka; Shuichi Ota; Takanori Ohta; Takafumi Kimura; Yoshinobu Kanda; Tatsuo Ichinohe; Yoshiko Atsuta; Hideki Nakasone; Satoko Morishima
Journal:  Bone Marrow Transplant       Date:  2021-01-08       Impact factor: 5.483

7.  Cytomegalovirus induces strong antileukemic effect in acute myeloid leukemia patients following sibling HSCT without ATG-containing regimen.

Authors:  Xiebing Bao; Qian Zhu; Shengli Xue; Xiaohui Hu; Xiao Ma; Feng Chen; Suning Chen; Aining Sun; Depei Wu; Jianhua Yu; Xiaojin Wu; Huiying Qiu
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

8.  The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins.

Authors:  Jenny Odeberg; Helena Browne; Sunil Metkar; Christopher J Froelich; Lars Brandén; David Cosman; Cecilia Söderberg-Nauclér
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

9.  Effects of Chlamydia trachomatis infection on the expression of natural killer (NK) cell ligands and susceptibility to NK cell lysis.

Authors:  C E Hook; N Telyatnikova; J C Goodall; V M Braud; A J Carmichael; M R Wills; J S H Gaston
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

10.  CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML.

Authors:  S Ito; P Pophali; Wu CO; E K Koklanaris; J Superata; G A Fahle; R Childs; M Battiwalla; A J Barrett
Journal:  Bone Marrow Transplant       Date:  2013-04-08       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.